Match tier Likely match
Presence Current · Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-08-15

Xixi Zhao

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

Also affiliated: QB3 (2024–2025); Apple (Israel) (2017); University Medical Center Groningen (2020–2021); The University of Texas MD Anderson Cancer Center (2018–2022); Lawrence Berkeley National Laboratory (2024–2025); University of Groningen (2020); Shanghai Jiao Tong University (2025); Dalian Medical University (2023); Chinese Academy of Sciences (2023); Ningxia University (2025); University of California System (2025); Guangzhou Center for Disease Control and Prevention (2006); North West Agriculture and Forestry University (2024–2025); The Fifth People's Hospital of Anyang (2025); Quantitative BioSciences (2025); Second Affiliated Hospital of Dalian Medical University (2023); Stanford Health Care (2023); First Affiliated Hospital of Xi'an Jiaotong University (2017); Second Affiliated Hospital of Xi'an Jiaotong University (2015–2025); Shenzhen Institutes of Advanced Technology (2023); Joint BioEnergy Institute (2024–2025); Southern Medical University (2018); Xi'an Jiaotong University (2015–2018); Northwest A&F University (2023–2025); University of California, Berkeley (2024–2025)

Faculty Researcher

21 h-index 75 pubs 1,677 cited

  • Humans
  • Saccharomyces cerevisiae
  • Breast Neoplasms
  • Female
  • Animals
  • Triple Negative Breast Neoplasms
  • Fermentation
  • Prognosis
  • Tumor Microenvironment
  • Metabolic Engineering
  • Mice
  • Vitis
  • Apoptosis
  • Biosynthetic Pathways
  • B7-H1 Antigen

Biography and Research Information

OverviewAI-generated summary

Xixi Zhao's research focuses on applying engineering and computational methods to biological systems. She has investigated the complete biosynthesis of QS-21 in engineered yeast and the engineering of *Saccharomyces cerevisiae* as a platform for nucleotide sugar biosynthesis. Her work also includes the dynamic upregulation of rate-limiting enzymes for valerolactam biosynthesis in *Corynebacterium glutamicum*.

In the health sciences, Zhao has utilized machine learning to predict the prognosis of breast cancer patients, specifically those with brain or bone metastases. She has also explored the role of Vitamin C in inhibiting PD-L1 and enhancing T cell function in triple-negative breast cancer (TNBC), and investigated how phosphorylation and stabilization of PD-L1 by CK2 suppresses dendritic cell function. Her publications include work on reducing higher alcohols during kiwifruit wine fermentation.

Metrics

  • h-index: 21
  • Publications: 75
  • Citations: 1,677

Selected Publications

  • Endophytic filamentous fungi in grapes and wine: identification, interaction, role and mechanism, potential application, and challenge (2025)
    Critical Reviews in Food Science and Nutrition DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

8 Collaborators 2 Institutions 2 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics